Trial reportObesity surgery2025
Long Biliopancreatic Limb (BPL) RYGB Versus Short BPL RYGB Post-Suboptimal Initial Clinical Response of SG or Recurrent Weight Gain: A Randomized Controlled Study.
Trial report in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRoux-en-Y gastric bypass (RYGB) has long been one of the main metabolic and bariatric choices. It has been the most frequently used conversional procedure for a sleeve gastrectomy (SG) with suboptimal initial clinical response (SoCR) or recurrent weight gain (RWG). RYGB provides its effect through both dietary restriction and malabsorption, with efficient weight and metabolic control relating to the excluded gut. This study was designed to investigate the effect of long biliopancreatic limb (BPL) RYGB versus short BPL RYGB post-SoCR or RWG of SG on weight loss and metabolic profile. PATIENTS AND
methodsThis is a randomized controlled trial that included patients who had undergone SG with SoCR or RWG and were equally enrolled in the long BPL (LRYGB-LBPL) group and the short BPL group (LRYGB-SBPL). The patients were followed for 1 year, and weight loss, metabolic profile, and postoperative complications were analyzed. The LRYGB-LBPL group showed statistically significant improvements in EBMIL%, HbA1c reduction, and HDL levels, while other outcomes showed no significant differences. This study's findings suggest that extending the BPL length in conversional RYGB may enhance the procedure's effectiveness in certain aspects of weight reduction and metabolic profile, although many outcomes were similar between groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.